New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 18, 2014
04:55 EDTIART, IARTIntegra LifeSciences management to meet with Jefferies
Meeting to be held in Los Angeles on March 21 hosted by Jefferies.
News For IART From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
10:02 EDTIARTOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ACE Limited (ACE) upgraded to Outperform at Bernstein on Chubb deal potential... Aixtron (AIXG) upgraded to Outperform from Neutral at Exane BNP Paribas... Anglo American (AAUKY) upgraded to Neutral from Underperform at Exane BNP Paribas... Antero Resources (AR) upgraded to Buy from Accumulate at KLR Group... Autoliv (ALV) upgraded to Outperform from Neutral at Credit Suisse... Barrick Gold (ABX) upgraded to Hold from Sell at Canaccord... California Water Service (CWT) upgraded to Buy from Neutral at Hilliard Lyons... Calpine (CPN) upgraded to Buy from Hold at Evercore ISI... CenturyLink (CTL) upgraded to Hold from Underperform at Jefferies... China Unicom (CHU) upgraded to Hold from Reduce at HSBC... Chubb (CB) upgraded to Outperform from Market Perform at Bernstein... Delphi (DLPH) upgraded to Buy from Outperform at CLSA... Diebold (DBD) upgraded to Outperform from Neutral at Wedbush... Discovery (DISCA) upgraded to Neutral from Sell at UBS... Eldorado Gold (EGO) upgraded to Buy at Canaccord... GoPro (GPRO) upgraded to Buy with $90 price target at Citi... Guidance Software (GUID) upgraded to Buy from Hold at Gabelli... H&E Equipment (HEES) upgraded to Buy from Neutral at UBS... Integra LifeSciences (IART) upgraded to Overweight from Neutral at JPMorgan... Lenovo (LNVGY) upgraded to Hold from Underperform at Jefferies... Methanex (MEOH) upgraded to Buy from Hold at TD Securities... Molina Healthcare (MOH) upgraded on strong results at Stifel... NCI, Inc. (NCIT) upgraded to Outperform from Market Perform at Cowen... Nationstar (NSM) upgraded to Market Perform from Underperform at FBR Capital... NetScout (NTCT) upgraded at Sterne Agee CRT... Pacira (PCRX) upgraded to Neutral from Underperform at BofA/Merrill... Premiere Global (PGI) upgraded to Strong Buy from Outperform at Raymond James... Regal Entertainment (RGC) upgraded to Outperform from Neutral at Wedbush... ResMed (RMD) upgraded to Overweight from Equal Weight at Morgan Stanley... RingCentral (RNG) upgraded to Strong Buy from Outperform at Raymond James... Robert Half (RHI) upgraded to Buy from Hold at Jefferies... SkyWest (SKYW) upgraded to Buy from Hold at Evercore ISI... Stratasys (SSYS) upgraded to Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Buy from Hold at Argus... Western Union (WU) upgraded to Equal Weight from Underweight at Barclays... Yahoo Japan (YAHOY) upgraded to Buy from Hold at Jefferies... eHealth (EHTH) upgraded to Neutral from Underperform at BofA/Merrill.
09:36 EDTIARTIntegra LifeSciences upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Christopher Pasquale upgraded Integra LifeSciences to Overweight with an $80 price target saying the stock has upside now that the portfolio reshuffle is complete.
09:31 EDTIARTIntegra LifeSciences upgraded to Overweight from Neutral at JPMorgan
Subscribe for More Information
July 30, 2015
10:14 EDTIARTIntegra LifeSciences sees Q3 revenue $222M-$228M, consensus $221.54M
Subscribe for More Information
06:25 EDTIARTIntegra LifeSciences sees FY15 adjusted EPS $3.00-$3.10, consensus $3.11
Sees FY15 revenue $870M-$885M, consensus $871.57M. "The new guidance range for 2015 continuing operations is consistent with our prior expectations. This new guidance reflects the removal of our spine business for the full year, which is expected to have a $0.20 dilutive impact to adjusted EPS, and the slight accretion we expect from the TEI acquisition, net of any financing impact we expect to incur in the second half of 2015," said Glenn Coleman, Integra's CFO. "We are maintaining our expectations for the underlying business excluding these transactions."
06:24 EDTIARTIntegra LifeSciences reports Q2 adjusted EPS 79c, consensus 72c
Subscribe for More Information
July 29, 2015
10:00 EDTIARTOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: 3D Systems (DDD) upgraded to Neutral from Underperform at Longbow... AK Steel (AKS) upgraded to Outperform from Neutral at Macquarie... Ally Financial (ALLY) upgraded to Outperform from Neutral at Credit Suisse... Amazon.com (AMZN) upgraded to Buy from Hold at Stifel... Arrow Electronics (ARW) upgraded to Buy from Underperform at CLSA... Beacon Roofing (BECN) upgraded to Buy from Neutral at CL King... Citrix (CTXS) upgraded to Outperform at Baird... Commvault (CVLT) upgraded to Buy from Hold at Jefferies... FireEye (FEYE) upgraded on positive checks, business mdoel changes at Oppenheimer... Hibbett Sports (HIBB) upgraded to Neutral from Underperform at Sterne Agee CRT... Integra LifeSciences (IART) upgraded to Outperform at Raymond James... M/A-COM (MTSI) upgraded to Buy from Hold at Needham... Norsk Hydro (NHYDY) upgraded to Neutral from Underperform at Exane BNP Paribas... NuVasive (NUVA) upgraded to Outperform from Market Perform at Northland... SM Energy (SM) upgraded to Outperform from Market Perform at Raymond James... Scorpio Bulkers (SALT) upgraded to Buy from Hold at Deutsche Bank... Sirius XM (SIRI) upgraded to Buy from Hold at Wunderlich... Sprouts Farmers Markets (SFM) upgraded to Neutral from Underperform at Longbow... Supervalu (SVU) upgraded to Equal Weight from Underweight at Morgan Stanley... Waters (WAT) upgraded to Outperform from Market Perform at Wells Fargo... Wells Fargo (WFC) upgraded to Buy from Neutral at Guggenheim... Williams-Sonoma (WSM) upgraded to Overweight from Neutral at JPMorgan... YRC Worldwide (YRCW) upgraded to Strong Buy at Raymond James.
07:39 EDTIARTIntegra LifeSciences upgraded to Outperform at Raymond James
Raymond James upgraded Integra LifeSciences to Outperform from Market Perform with a $73 price target. The firm said execution is improving, visibility is at a high, and the high margin product cycle coupled with capital deployment should improve sentiment and drive shares higher.
July 20, 2015
06:04 EDTIARTSeaSpine selling pressure may be over, says at Piper Jaffray
Piper Jaffray points out that shares of SeaSpine (SPNE) are down 15% since their spin-off from Integra LifeSciences (IART) on June 17. Piper attributes the weakness to non-fundamental selling by existing Integra shareholders and its analysis indicates that the worst of the selling pressure might be over. The firm keeps an Overweight rating on SeaSpine with a $24 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use